Bone marrow cell treatment as treatment of multiple sclerosis
Treatment of autologous mesenchymal stem cells derived from bone marrow as a potential therapeutic strategy for the treatment of multiple sclerosis
What was tested
Treatment tested
- Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved
What it measured
Main measures
Safety and tolerability
Safety
Other measures (1)
Lesions that enhance with gadolinium T1 in sequence magnetic resonance
MRI lesions
Papers
Loading reviews and guidelines…
Related trials
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory
Phase 1 · Not yet recruiting
Still running
- A Study of C-CAR168 in the Treatment of Central Nervous System Autoimm
Phase 1 · Not yet recruiting
Still running
- Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimm
Phase 1 · Withdrawn
Stopped
- Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases
Early phase 1 · Not yet recruiting
Still running
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory
Phase 1 · Recruiting
Still running
- Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoi
Status unknown
No results found
History
- In scope changed from true to false
Started
Jan 2014
Assembled by software from public sources.